Welcome to our dedicated page for Zedcor news (Ticker: CRFQF), a resource for investors and traders seeking the latest updates and insights on Zedcor stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zedcor's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zedcor's position in the market.
Zedcor announced the election of directors at its annual meeting on May 23, 2024. The elected directors are Wade Felesky, Brian McGill, Dean Swanberg, Dean Shillington, and Todd Ziniuk.
The company also granted options to purchase 2,150,000 common shares at $1.25 per share to non-management directors and the corporate secretary. These options, part of a 10% rolling stock option plan, will vest over three years and expire in five years.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Zedcor (CRFQF)?
